Accrue
Log inGet Access

0x7f2bdc...622a27

0x7f2bdc...622a27
#15073 overall · top 71.56%
Smart Score
5
Win Rate
50.0%
Total P&L
+$1
Trade Count
931
Sharpe Ratio
-9.99
Sortino Ratio
-9.99
Max Drawdown
13930.5%
ROI
0.0%
Profit Factor
1.88
Kelly Fraction
0.234
R² (Curve Fit)
—
Smart Score
05/100100

Recent Trades

MarketSidePriceSizeTime
FDA approves Retatrutide this year?SELL21.3¢176.04Jan 30
FDA approves Retatrutide this year?BUY23.0¢86.957Jan 30
FDA approves Retatrutide this year?BUY23.0¢86.957Jan 30
FDA approves Retatrutide this year?BUY22.0¢1.282Jan 30
FDA approves Retatrutide this year?SELL22.0¢6.47Jan 30
FDA approves Retatrutide this year?BUY22.0¢5.92Jan 30
FDA approves Retatrutide this year?SELL22.0¢5.92Jan 30
FDA approves Retatrutide this year?BUY22.0¢6.25Jan 30
FDA approves Retatrutide this year?SELL22.0¢6.25Jan 30
FDA approves Retatrutide this year?BUY22.0¢0.58Jan 30
FDA approves Retatrutide this year?BUY22.0¢0.76Jan 30
FDA approves Retatrutide this year?BUY22.0¢5Jan 30
FDA approves Retatrutide this year?BUY22.0¢0.97Jan 30
FDA approves Retatrutide this year?SELL22.0¢8.4Jan 30
FDA approves Retatrutide this year?BUY22.0¢8.4Jan 30
FDA approves Retatrutide this year?SELL22.0¢74.68Jan 30
FDA approves Retatrutide this year?BUY22.0¢74.68Jan 30
FDA approves Retatrutide this year?SELL22.0¢59.96Jan 30
FDA approves Retatrutide this year?BUY22.0¢59.96Jan 30
FDA approves Retatrutide this year?SELL22.0¢85.49Jan 30

Analytics Showcase

Full analytics →
Odds DistributionContrarian / Long-Shot Hunter

Entry price distribution — reveals preference for long shots vs safe bets

100%75%50%25%< 10%10–20%99%20–30%30–50%50–70%70–80%80–90%> 90%
← Long ShotsSafe Bets →
Quantitative Edge Profile
Developing5

Multi-dimensional edge evaluation as a quant desk would assess a portfolio manager

Risk-Adjusted Return (Sharpe)0.28
Equity Curve R² (Linear Fit)4.5%
Win Consistency0.0%
Profit Factor0.13
Drawdown Resilience0.11
Conviction Sizing (Kelly)0.11
Weekly Sharpe est.0.08

Showcase profile — live & interactive · 52-week window

Copy this trader

Preview data · updated daily · full equity curve & more at accrue.com/platform